Growing Dividends, Acquisitions, Awards for Innovation, Financial Grants, and New Appointments - Research Report on Medtronic, Wright, Sirona, Align, and MAKO

NEW YORK, June 25, 2013 /PRNewswire/ --

Today, Wall Street Reports announced new research reports highlighting Medtronic, Inc. (NYSE: MDT), Wright Medical Group, Inc. (NASDAQ: WMGI), Sirona Dental Systems, Inc. (NASDAQ: SIRO), Align Technology, Inc. (NASDAQ: ALGN), and MAKO Surgical Corp. (NASDAQ: MAKO). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Medtronic, Inc. Research Report

On June 20, 2013, the Board of Directors of Medtronic, Inc. (Medtronic) approved an 8% increase in the Company's cash dividend, raising the quarterly amount to $0.28 per share of Medtronic's common stock, resulting in an annual amount of $1.12 per share. Medtronic reported that the dividend increase brings the Company's dividend yield to 2.2% and expected FY 2014 dividend payout ratio to approximately 30%. The 8% dividend increase marks Medtronic's 36^th consecutive year of increased dividend payments. The Company stated that the dividend will be paid on July 26, 2013, to shareholders of record as of July 5, 2013. Further, the Board of Directors also approved an increase in the Company's Share Repurchase Plan and authorized the Company to purchase 80 million shares of its common stock, representing an approximately 8% of Medtronic's total basic shares of common stock outstanding. The Full Research Report on Medtronic, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/b199_MDT]

--

Wright Medical Group, Inc. Research Report

On June 19, 2013, Wright Medical Group, Inc. (Wright) announced a definitive agreement under which MicroPort Medical B.V. (MicroPort) will acquire Wright's OrthoRecon business for a price of $290 million. The deal is expected to close by the end of Q3 2013 or by early Q4 2013. OrthoRecon business consists of hip and knee implant products which generated global revenue of approximately $269 million in 2012. According to industry research, the global hip and knee reconstruction market was estimated to be worth approximately $14 billion in 2012. The research also indicated that the China hip and knee implant market is growing at approximately 17% per year and is estimated to be worth approximately $1.3 billion by 2018. After closing of the transaction, Wright stated that the OrthoRecon business will continue to be headquartered in Arlington, Tennessee and that Ted Davis, current President of Wright's OrthoRecon business, will lead the MicroPort Orthopedic business. The Full Research Report on Wright Medical Group, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/1f8a_WMGI]

--

Sirona Dental Systems, Inc. Research Report

On June 3, 2013, Sirona Dental Systems, Inc. (Sirona) announced that its CEREC Omnicam was awarded the most innovative product in dentistry at the recently held Clinical Innovations Conference. The award was presented by Mash Seriki, CEO of Healthcare Learning Company Ltd. Sirona reported that the features of CEREC Omnicam that stand out include its ability to support video streaming, to digitize the structures of the jaw in their natural color, and the non-requirement of powder coating of the tooth surfaces. Sirona further stated that the CEREC Omnicam demonstrates the Company's power of innovation. The Full Research Report on Sirona Dental Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/04e6_SIRO]

--

Align Technology, Inc. Research Report

On June 19, 2013, Align Technology, Inc. (Align) announced that it has awarded $220,000 in new funding to five universities in North America and seven international universities for projects seeking to better understand orthodontic treatment with clear aligners and use of orthodontic scanners. "We are pleased to see continued and growing interest in our research awards program - the number of applications we received this year was substantially greater than received in previous years," said John Morton, Director of Research and Technology at Align. "Align recognizes that university research is fundamental and vital to improving dental and orthodontic care, and we are excited about the research to be conducted as part of these grants." Dr. Mitra Derakhshan, Director of Clinical International at Align, commented, "The growth of Invisalign in the European and other international markets is a direct reflection of the investment Align is making in those markets, a key component of which is the university research program." The Full Research Report on Align Technology, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/67be_ALGN]

--

MAKO Surgical Corp. Research Report

On June 3, 2013, MAKO Surgical Corp. (MAKO) announced the appointment of Ian Dawson to the position of Senior Vice President of Marketing. Dawson assumes the responsibility for the Company's commercial marketing activities, which were formerly supervised by Ivan Delevic, who is transitioning to the position of Senior Vice President of Corporate Development for MAKO. As per the Company, Dawson and Delevic will report to Maurice R. Ferré, M.D., President and CEO of MAKO. Ian Dawson has over 25 years of experience in marketing, with the majority of his experience in the medical device field. Till recently, he served as Vice President of North America Marketing for Smith & Nephew Advanced Wound Management from June 2008 through May 2013. "Based on his impressive background and experience in orthopedics, Ian will be a valuable addition to the MAKO team," commented Dr. Ferré. The Full Research Report on MAKO Surgical Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/7865_MAKO]

----

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
5. For any urgent concerns or inquiries, please contact us at [email protected].
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE Wall Street Reports